Regionshospital Nordjylland

Bletrltwrto 3vd Hvspkmogp 9eabd Dsvwums

Cardiovascular Diseases

At Regionshospital Nordjylland the Department of Anesthesiology and Intensive Care is conducting studies aimed at improving outcomes for patients with cardiovascular conditions. Trials are testing novel agents to lower the risk of death or hospitalization in chronic heart failure and to prevent stroke in people with atrial fibrillation. Research also explores rapid‑response treatments during in‑hospital cardiac arrest to increase survival rates.

ASCVD – Atherosclerotic Cardiovascular Disease
Chronic Heart Failure With Reduced Ejection Fraction
In‑hospital cardiac arrest
Prevention of stroke or systemic embolism in atrial fibrillation

With a team of 11 investigators, the site is contributing valuable data to the global effort against heart disease.

Immune System Processes

The department is also active in pediatric infectious‑disease research, focusing on protection against respiratory syncytial virus (RSV). A vaccine‑based study evaluates safety and the ability to prevent medically attended lower respiratory infections in infants.

Prevention of RSV in healthy infants

Based in Hjørring, Denmark, the centre collaborates with international partners to accelerate vaccine development.

#1 Clinical Trials Search in Europe

Regionshospital Nordjylland

Cardiovascular Diseases

Immune System Processes

Study of new chickenpox vaccine and measles-mumps-rubella vaccine given by intramuscular injection in healthy children aged 12 to 15 months

Study on Baxdrostat and Dapagliflozin for Preventing Heart Failure in Patients at High Risk

Study Comparing Aspirin Alone to Aspirin and Fondaparinux in Patients with Non-ST-Elevation Myocardial Infarction (NSTEMI)

Study on Fluid Removal Using Furosemide and Amiloride Hydrochloride in ICU Patients with Fluid Overload

Study Comparing Meropenem and Piperacillin/Tazobactam for Adults with Sepsis

Study of Zenagamtide (NNC0487-0111) versus placebo in patients with heart failure with preserved or mildly reduced ejection fraction and obesity

Methotrexate tapering versus usual care in elderly (≥70) patients with rheumatoid arthritis in low disease activity – drug combination study

Study on the Immune Response and Safety of a Second Dose of Investigational Varicella Vaccine (GSKVX000000025896) Compared to Varicella Virus Oka/Merck Strain in Healthy Children

Study on MK-0616 for Reducing Heart Disease Events in Patients with Atherosclerotic Cardiovascular Disease

Study on the Safety and Immune Response of MenACYW Conjugate Vaccine Compared to a Drug Combination in Healthy Infants and Toddlers

Regionshospital Nordjylland

Cardiovascular Diseases

Immune System Processes

We use cookies